Cartalax (23mg)

Description

Cartalax (Cartilage-Derived Regenerative Peptide)

Cartalax is a synthetic peptide derived from natural cartilage matrix components. It has been modified with lipophilic properties to enhance bioavailability and targeted delivery to joint tissues. It is primarily researched for its potential regenerative effects on cartilage and overall joint health.

Research Properties:

• Cartilage Regeneration: Studied for its ability to stimulate chondrocyte proliferation and support collagen synthesis, potentially aiding in the repair of damaged cartilage.
• Anti-Inflammatory Effects: Research suggests it may help reduce pro-inflammatory cytokine activity within joint tissues.
• Joint Support: Investigated for its role in promoting synovial fluid production, which may improve joint lubrication and cushioning.
• Tissue Repair: Explored for accelerating recovery following joint stress or degenerative conditions.

Key Areas of Research Interest:

• Osteoarthritis and degenerative joint disease
• Cartilage repair and regeneration
• Joint inflammation and mobility
• Post-injury joint recovery

Administration in Research:

• Subcutaneous injection (SQ)
• Intra-articular injection (IA) – direct joint injection

For Research Use Only. Not for human consumption. Cartalax is intended strictly for laboratory research and in-vitro experimentation.